Title
Category
Credits
Event date
Cost
Recorded - The Efficacy, Safety, and Overuse of Ceftriaxone: An Antimicrobial Stewardship Discussion
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This program provides a comprehensive overview of ceftriaxone, focusing on its mechanism of action, spectrum of activity, and key pharmacokinetic and pharmacodynamic properties. Participants will learn about its major adverse effects, drug interactions, and clinical uses, with a special focus on recent reports of adverse events in Alabama. The discussion will emphasize the importance of antimicrobial stewardship in preventing the overuse of ceftriaxone and ensuring safe, effective treatment.
Recent Updates for the Management of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
11/11/2025
$0.00
Urinary tract infections (UTIs) are one of the most common infectious diseases in the outpatient, long-term care, and inpatient settings.  In 2025, new treatment guidelines were released that updated the definitions for uncomplicated urinary tract infections (uUTIs) from complicated UTIs (cUTIs), as well as updated the treatment recommendations for cUTIs, such as pyelonephritis.  Healthcare providers must be familiar with these new recommendations to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the developm
ENCORE - Recent Updates for the Management of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
11/13/2025
$0.00
Urinary tract infections (UTIs) are one of the most common infectious diseases in the outpatient, long-term care, and inpatient settings.  In 2025, new treatment guidelines were released that updated the definitions for uncomplicated urinary tract infections (uUTIs) from complicated UTIs (cUTIs), as well as updated the treatment recommendations for cUTIs, such as pyelonephritis.  Healthcare providers must be familiar with these new recommendations to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the developm
Recent Updates for the Management of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
12/04/2025
$0.00
Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship
ENCORE Recent Updates for the Management of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
12/09/2025
$0.00
Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship

Pages